US Patent Issued to ABBOT DIABETES CARE on Aug. 4 for "Methods, devices, and systems for adjusting laboratory HBA1C values" (California Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,699,105, issued on Aug. 4, was assigned to ABBOT DIABETES CARE INC. (Alameda, Calif.).

"Methods, devices, and systems for adjusting laboratory HBA1C values" was invented by Yongjin Xu (San Ramon, Calif.) and Timothy C. Dunn (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Physiological parameters that related to the kinetics of red blood cell hemoglobin glycation, red blood cell elimination, and red blood cell generation within the body of a subject can be used, for example, to calculate a more reliable calculated HbA1c (cHbA1c), adjusted HbA1c (aHbA1c), and/or a personalized target glucose range, among other things, for subject-personalized...